Phase II study of ramucirumab and docetaxel for previously platinum-treated patients with non-small cell lung cancer and malignant pleural effusion (PLEURAM study).
Takemoto S, Fukuda M, Ogata R, Senju H, Sugasaki N, Nakatomi K, Tomono H, Suyama T, Sasaki E, Matsuo M, Akagi K, Hayashi F, Dotsu Y, Ono S, Honda N, Taniguchi H, Gyotoku H, Ikeda T, Nagashima S, Soda H, Kinoshita A, Mukae H.
Takemoto S, et al. Among authors: sasaki e.
Transl Lung Cancer Res. 2024 Oct 31;13(10):2673-2682. doi: 10.21037/tlcr-24-508. Epub 2024 Oct 24.
Transl Lung Cancer Res. 2024.
PMID: 39507035
Free PMC article.